Kazuki Kakimoto
9PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 27, 2025
A Clinical Prediction Model for Early Colectomy in Patients With Severe Ulcerative Colitis Treated With Tacrolimus.Hikaru Shimizu, Kazuki Kakimoto, Mai Utsumi
|Aug 29, 2024
C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis.Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta
|Jul 13, 2024
Correction: Tatsumi et al. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. J. Clin. Med. 2023, 12, 7165.Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara
|Nov 25, 2023
Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara
|Oct 28, 2023
Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis.Keijiro Numa, Kazuki Kakimoto, Yasuyoshi Tanaka
|Sep 09, 2022
Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis.Naohiko Kinoshita, Kazuki Kakimoto, Hikaru Shimizu
Pageof 2